Immunological factors in the pathogenesis and treatment of age-related macular degeneration

Ocular Immunology and Inflammation

Volumn 13, Issue 1, 2005, Pages 3-11

  Kijlstra, A ^a   La Heij, E C ^a   Hendrikse, F ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age related macular degeneration; Anti inflammatory drugs; Chlamydia pneumoniae; Complement system; Retinal transplantation

Indexed keywords

ANECORTAVE; ANTIINFLAMMATORY AGENT; BENZOPORPHYRIN DERIVATIVE; CD18 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PEGAPTANIB; PIGMENT EPITHELIUM DERIVED FACTOR; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN; VASCULOTROPIN C;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; CATARACTOGENESIS; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENT SYSTEM; DISEASE MODEL; DRUSEN; ENDOPHTHALMITIS; HUMAN; IMMUNOTHERAPY; INTRAOCULAR PRESSURE ABNORMALITY; ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SIDE EFFECT; TRANSPLANTATION; UVEITIS; CHOROID; CYTOLOGY; IMMUNE SYSTEM; IMMUNOLOGY; IRIS; PHYSIOLOGY; PIGMENT EPITHELIUM; RETINA; RETINA MACULA DEGENERATION;

ANTI-INFLAMMATORY AGENTS; AUTOIMMUNITY; CHOROID; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; IRIS; MACULAR DEGENERATION; PIGMENT EPITHELIUM OF EYE; RETINA;

EID: 17844409078     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940590909185     Document Type: Review

References (75)

1. Klein R, Wang Q, Klein BEK, Moss SE, Meuer SE. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Visual Sci. 1995;36(1):182-191.
2. Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol. 1990;228(3):270-274.
3. Gurne DH, Tso MOM, Edward DP, Ripps H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology. 1991;98(5):602-607.
4. Doekes G, Van Der Gaag R, Rothova A, Van Kooyk Y, Broersma L, Zaal MJ, Dijkman G, Fortuin ME, Baarsma GS, Kijlstra A. Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res. 1987;6:909-919.
5. De Smet MD, Chan CC. Regulation of ocular inflammation-what experimental and human studies have taught us. Prog Retin Eye Res. 2001;20:761-797.
6. Penfold PL, Madigan MC, Gillies MC, et al. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385-414.
7. Higgins GT, Wang JH, Dockery P, et al. Induction of angiogenic cytokine expression in cultured RPE by ingestion of oxidized photoreceptor outer segments. Invest Ophthalmol Visual Sci. 2003;44:1775-1782.
8. Hageman GS, Luthert PJ, Chong NHV, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20(6):705-732.
9. Blaauwgeers HGT, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, Van Hinsbergh VWM, Schlingemann RO. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol. 1999:155(2):421-428.
10. Holtkamp GM, Van Rossem M, De Vos AF, Willekens B, Peek R, Kijlstra A. Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol. 1998;112(1):34-43.
11. Holtkamp GM, De Vos AF, Peek R, Kijlstra A. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta 2) by human retinal pigment epithelial cells. Clin Exp Immunol. 1999;118(1):35-40.
12. Radisavljevic Z, Avraham H, Avraham S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem. 2000;275(27):20770-20774.
13. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG, Cousins SW. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Visual Sci. 2003;44(8):3586- 3592.
14. Sakurai E, Anand A, Ambati BK, Van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Visual Sci. 2003;44(8):3578-3585.
15. Anderson DH, Mullins RF, Hageman GS, Johnson LV Perspective-A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134(3):411-431.
16. Nauta AJ, Daha MR, Van Kooten C, et al. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 2003;24(3):148-154.
17. Van der Schaft TL, Mooy CM, Debruijn WC, Dejong PTVM. Early stages of age-related macular degeneration-an immunofluorescence and electron-microscopy study. Br J Ophthalmol. 1993;77(10):657-661.
18. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res. 2001;73(6):887-896.
19. Newsome DA, Hewitt AT, Huh W, Robey PG, Hassell JR. Detection of specific extracellular matrix molecules in drusen, Bruch's membrane, and ciliary body. Am J Ophthalmol. 1987;104:373-381.
20. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res. 2000;70(4):441-449.
21. McLaughlin BJ, Fan W, Zheng JJ, et al. Novel role for a complement regulatory protein (CD46) in retinal pigment epithelial adhesion. Invest Ophthalmol Visual Sci. 2003;44(8):3669-3674.
22. Fukuoka Y, Strainic M, Medof ME. Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a. Clin Exp Immunol. 2003;131:248-253.
23. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846.
24. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99(18):11830-11835.
25. Dentchev T, Milam AH, Lee VMY, et al. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis. 2003;9:184-190.
26. Van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann NY Acad Sci. 2003;992:56-71.
27. Forrester JV, McMenamin PG, Holthouse I, Lumsden L, Liversidge J. Localization and characterization of major histocompatibility complex class n-positive cells in the posterior segment of the eye-implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Visual Sci. 1994;35:64-77.
28. Chen L, Zwart R, Yang PZ, Kijlstra A. Macrophages and MHC class II positive dendritiform cells in the iris and choroid of the pig. Curr Eye Res. 2003;26:291-296.
29. Wang JJ, Mitchell P, Smith W, et al. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2003;10:37-48.
30. Wang YS, Friedrichs U, Eichler W, Hoffmann S, Wiedemann P. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefe's Arch Clin Exp Ophthalmol. 2002;240:42-48.
31. Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol. 2001;119:399-404.
32. Ranson NT, Danis RP, Ciulla TA, Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol. 2002;86:527-529.
33. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor ABL, Chua W, Mitchell P, Billson F. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one year results. Arch Ophthalmol. 2003;121:667-673.
34. JonasJB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol. 2003;87:462-468.
35. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology. 2003;110:1517-1525.
36. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003;87:24-27.
37. Sutter FKP, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol. 2003;87(8):972-974.
38. Penn JS, Rajaratnam VS, Collier RJ, Clark AF. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Visual Sci. 2001;42(1):283-290.
39. Blinder K, Blumenkranz M, DeSmet M, Fish G, Friedlander M, Gitter K, Godley B, Ho A, Hudson H, Van Kuijk E, Lewis ML, Rosenfeld P, Russell S, Sabates F, Schachat A, Schmidt-Erfurth U, Schwartz S, Singerman L, Soubrane G, Yannuzzi L, D'Amico DJ, Regillo C, Mieler WF, Schneebaum C, BeasleyC, Slakter JS, Ciardella A, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD)-interim (month 6) analysis of clinical safety and efficacy. Retina J Retin Vitreous Dis. 2003;23:14-23.
40. Miller DM, Legra JM, Dubovy SR, Suner IJ, Dix RD, Sedmak DD, Cousins SW. The association of exudative age-related macular degeneration with prior infection. Invest Ophthalmol Visual Sci. 203;45:ARVO E-abstract 1747.
41. Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol. 2003;121:478-482.
42. Ishida O, Oku H, Ikeda T, Nishimura M, Kawagoe K, Nakamura K. Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? Br J Ophthalmol. 2003;87:523-524.
43. Kalayoglu MV, Bula D, Arroyo J, Gragoudas ES, Miller JW. Detection of Chlamydia pneumoniae in choroidal neovascular membranes isolated from patients with age-related macular degeneration. Invest Ophthalmol Visual Sci. 2003;45:ARVO E-abstract 5023.
44. Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M, Singerman LJ, Slakter JS, Strong A, Vannier S, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials. TAP Report No. 5. Arch Ophthalmol. 2002;120:1307-1314.
45. Bora PS, Hu ZW, Tezel TH, Sohn JH, Kang SG, Cruz JMC, Bora NS, Garen A, Kaplan HJ. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc Natl Acad Sci USA. 2003;100:2679-2684.
46. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676.
47. Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997;81:154-162.
48. Kvanta A, Algvere PV, Berglin L, et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Visual Sci. 1996;37:1929-1934.
49. Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li WJ, Connolly E, O'Neill CA, Miller JW. Prevention of experimental choroidal neovascularization with intravitreal antivascular endothelial growth factor antibody fragment. Arch Ophthalmol. 2002;120:338-346.
50. Martin DF, Klein M, Haller J, et al. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina J Retin Vitreous Dis. 2002;22:143-152.
51. Fish G, Haller JA, Ho AC, Klein M, Loewenstein J, Martin D, Orth D, Rosen RB, Sanislo S, Schwartz SD, Singerman LJ, Williams G, Adamis AP, Blumenkranz M, Goldberg M, Gragoudas ES, Miller JW, Yannuzzi L, Guyer DR, O'Shaughnessy D, Patel S. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration-phase II study results. Ophthalmology. 2003;110:979-986.
52. Rosenfeld PJ, Villate N, Feuer WJ, Puliafito CA, McCluskey ER. Rhu-Fab V2 (anti-VEGF antibody fragment) in neovascular AMD: safety, tolerability, and efficacy of multiple, escalating dose intravitreal injections. Invest Ophthalmol Visual Sci. 2003;45:ARVO E-abstract 970.
53. Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol. 2001;189:323-333.
54. Mori K, Gehlbach P, Yamamoto S, Dub E, Zack DJ, Li QH, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Visual Sci. 2002;43:1994-2000.
55. Otani A, Takagi H, Oh H, Koyama S, Matsumura M, Honda Y. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes. Invest Ophthalmol Visual Sci. 1999;40:1912-1920.
56. Binder S, Stolba U, Krebs I, Kellner L, Jahn C, Feichtinger H, Povelka M, Frohner U, Kruger A, Hilgers RD, Krugluger W Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol. 2002;133:215-225.
57. Phillips SJ, Sadda SR, Tso MOM, Humayan MS, de Juan E, Binder S. Autologous transplantation of retinal pigment epithelium after mechanical debridement of Bruch's membrane. Curr Eye Res. 2003;26:81-88.
58. Holz FG, Bindewald A, Schutt F, Specht H. Intraocular microablation of choroidal tissue by a 308 nm AIDA excimer laser for RPE-transplantation in patients with age-related macular degeneration. Biomed Tech. 2003;48:82-85.
59. Van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003;136:688-695.
60. Humayun MS, de Juan E, del Cerro M, Dagnelie G, Radner W, Sadda SR, del Cerro C. Human neural retinal transplantation. Invest Ophthalmol Visual Sci. 2000;41:3100-3106.
61. Berger AS, Tezel TH, Del Priore LV, Kaplan HJ. Photoreceptor transplantation in retinitis pigmentosa-short-term follow-up. Ophthalmology. 2003;110:383-391.
62. Del Cerro M, Humayun MS, Sadda SR, Cao JT, Hayashi N, Green WR, del Cerro C, de Juan E. Histologic correlation of human neural retinal transplantation. Invest Ophthalmol Visual Sci. 2000;41:3142-3148.
63. Lappas A, Weinberger WA, Foerster AMH, Kube T, Rezai KA, Kirchhof B. Iris pigment epithelial cell translocation in exudative age-related macular degeneration-a pilot study in patients. Graefe's Arch Clin Exp Ophthalmol. 2000;238:631-641.
64. Semkova I, Kreppel F, Welsandt G, Luther T, Kozlowski J, Janicki H, Kochanek S, Schraermeyer U. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc Natl Acad Sci USA. 2002;99:13090-13095.
65. Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. 2003;87:615-621.
66. Fujii GY, de Juan Jr E, Pieramici DJ, Humayun MS, Phillips S, Reynolds SM, Melia M, Schachat AR Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am J Ophthalmol. 2002;134:69-74.
67. Ohji M, Fujikado T, Kusaka S, Hayashi A, Hosohata J, Ikuno Y, Sawa M, Kubota A, Hashida N, Tano Y. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am J Ophthalmol. 2001;132:888-896.
68. Streilein JW, Ma NL, Wenkel H, Ng TF, Zamiri P. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res. 2002;42:487-495.
69. Wenkel H, Streilein JW. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Visual Sci. 1998;39:1823-1834.
70. Wenkel H, Streilein JW. Evidence that retinal pigment epithelium functions as an immune-privileged tissue. Invest Ophthalmol Visual Sci. 2000;41:3467-3473.
71. Ng TF, Osawa H, Hori J, et al. Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney. J Immunol. 2002;169:5601-5606.
72. Ma N, Streilein JW. Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts. Invest Ophthalmol Visual Sci. 1998;39:2384-2393.
73. Gouras P, Tanabe T. Survival and integration of neural retinal transplants in rd mice. Graefe's Arch Clin Exp Ophthalmol. 2003;241:403-409.
74. Kohen L, Enzmann V Faude F, Widermann P. Mechanisms of graft rejection in the transplantation of retinal pigment epithelial cells. Ophthalmic Res. 1997;29:298-304.
75. Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Visual Sci. 1998;39:1021-1027.